CARDIOVASCULAR (CV) RISK
Clinical trials for CARDIOVASCULAR (CV) RISK explained in plain language.
Never miss a new study
Get alerted when new CARDIOVASCULAR (CV) RISK trials appear
Sign up with your email to follow new studies for CARDIOVASCULAR (CV) RISK, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Study tests if workouts can boost fitness and heart health after menopause
Prevention CompletedThis study looked at whether an 8-12 week aerobic exercise program could improve fitness, heart health, and quality of life in postmenopausal women who get out of breath easily during physical activity. Researchers enrolled 43 inactive women to complete 24 training sessions. They…
Matched conditions: CARDIOVASCULAR (CV) RISK
Phase: NA • Sponsor: University of Poitiers • Aim: Prevention
Last updated Apr 01, 2026 23:41 UTC
-
Could ditching burgers help your heart? a 4-Week test
Knowledge-focused CompletedThis study aimed to see what happens to the heart and blood vessels when healthy young adults stop eating red and processed meat for four weeks. Researchers measured changes in blood pressure, cholesterol, and artery stiffness in 12 participants. The goal was to gather informatio…
Matched conditions: CARDIOVASCULAR (CV) RISK
Phase: NA • Sponsor: Maria Clara Rocha • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC
-
Scientists use insurance data to forecast major drug trial outcome
Knowledge-focused CompletedThis study aimed to predict the results of a major heart drug trial before it finishes. Researchers analyzed health insurance records from over 44,000 people with type 2 diabetes and heart disease to see if one diabetes drug (tirzepatide) is better than another (dulaglutide) at p…
Matched conditions: CARDIOVASCULAR (CV) RISK
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:32 UTC
-
Massive study pits popular Weight-Loss drugs against each other in heart health showdown
Knowledge-focused CompletedThis study analyzed health insurance records of nearly 900,000 people to compare how well different diabetes and weight management drugs protect against serious heart problems. It specifically looked at tirzepatide (Mounjaro/Zepbound) and semaglutide (Ozempic/Wegovy) versus other…
Matched conditions: CARDIOVASCULAR (CV) RISK
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Mar 25, 2026 14:09 UTC